发明名称 |
Mucosal adjuvant composition |
摘要 |
Problem to be Solved: The present invention provides a novel mucosal adjuvant.;Solution: The present invention provides a mucosal adjuvant composition containing at least a composition comprising molecules having a molecular weight in a range of 100 to 300 kDa obtained from cells or culture fluid of Bordetella bronchiseptica. Administration of the mucosal adjuvant composition to a non-human animal at a surface of the mucous membrane can enhance immunity at the surface of mucous membrane. Therefore preventive effects against trans-mucosal infection can be increased by administering an inactivated vaccine against trans-mucosal infection and the mucosal adjuvant composition to a non-human animal at a surface of mucous membrane. The present invention is effective for preventing trans-mucosal infections, including one or more infections of e.g., canine parainfluenza, canine adenovirus, canine coronavirus, canine parvovirus, canine distemper virus, canine herpesvirus, reovirus and pneumovirus. |
申请公布号 |
US9381241(B2) |
申请公布日期 |
2016.07.05 |
申请号 |
US201113876439 |
申请日期 |
2011.09.27 |
申请人 |
KYORITSU SEIYAKU CORPORATION |
发明人 |
Asai Ken-ichi;Kawakami Kazuo;Mochizuki Masami |
分类号 |
A61K39/00;A61K39/39;A61K38/16;C07K14/235;A61K39/12;A61K39/02 |
主分类号 |
A61K39/00 |
代理机构 |
Manelli Selter PLLC |
代理人 |
Melcher Jeffrey S.;Manelli Selter PLLC |
主权项 |
1. A method of preventing canine infectious tracheobronchitis the method comprising: administering to a subject an effective amount of a vaccine antigen against one or more infections of canine adenovirus and canine parainfluenza virus, and a mucosal adjuvant composition comprising molecules having a molecular weight in a range of 100 to 300 kDa obtained from cells or culture fluid of Bordetella bronchiseptica. |
地址 |
Ibaraki JP |